Invex Therapeutics Seeks Shareholder Approval for New Auditor

TipRanksOct 16 22:37 ET

Invex Therapeutics Embraces Corporate Governance Standards

TipRanksAug 22 02:31 ET

Invex Therapeutics Cuts Losses, Skips Dividend

TipRanksAug 22 02:18 ET

Invex Therapeutics Ltd: Appendix 4E and Annual Report to shareholders

Aug 22 02:05 ET · Announcements

Invex Therapeutics Finalizes Key Clinical Trial

TipRanksJul 23 01:47 ET

Invex Therapeutics (ASX:IXC) Shareholders Have Endured a 52% Loss From Investing in the Stock Three Years Ago

Yahoo FinanceJun 4 00:43 ET